» Articles » PMID: 36210813

Effects and Mechanisms of 6-hydroxykaempferol 3,6---glucoside-7--glucuronide from Safflower on Endothelial Injury and on Thrombosis

Overview
Journal Front Pharmacol
Date 2022 Oct 10
PMID 36210813
Authors
Affiliations
Soon will be listed here.
Abstract

The florets of L. (Safflower) is an important traditional medicine for promoting blood circulation and removing blood stasis. However, its bioactive compounds and mechanism of action need further clarification. This study aims to investigate the effect and possible mechanism of 6-hydroxykaempferol 3,6---glucoside-7--glucuronide (HGG) from Safflower on endothelial injury , and to verify its anti-thrombotic activity . The endothelial injury on human umbilical vein endothelial cells (HUVECs) was induced by oxygen-glucose deprivation followed by reoxygenation (OGD/R). The effect of HGG on the proliferation of HUVECs under OGD/R was evaluated by MTT, LDH release, Hoechst-33342 staining, and Annexin V-FITC apoptosis assay. RNA-seq, RT-qPCR, Enzyme-linked immunosorbent assay and Western blot experiments were performed to uncover the molecular mechanism. The anti-thrombotic effect of HGG was evaluated using phenylhydrazine (PHZ)-induced zebrafish thrombosis model. HGG significantly protected OGD/R induced endothelial injury, and decreased HUVECs apoptosis by regulating expressions of hypoxia inducible factor-1 alpha (HIF-1α) and nuclear factor kappa B (NF-κB) at both transcriptome and protein levels. Moreover, HGG reversed the mRNA expression of pro-inflammatory cytokines including , , and , and reduced the release of IL-6 after OGD/R. In addition, HGG exhibited protective effects against PHZ-induced zebrafish thrombosis and improved blood circulation. HGG regulates the expression of HIF-1α and NF-κB, protects OGD/R induced endothelial dysfunction and has anti-thrombotic activity in PHZ-induced thrombosis .

Citing Articles

Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation.

Li S, Liu P, Feng X, Du M, Zhang Y, Wang Y Front Cardiovasc Med. 2023; 10:1111475.

PMID: 36776258 PMC: 9909180. DOI: 10.3389/fcvm.2023.1111475.

References
1.
Wei A, Xiao H, Xu G, Yu X, Guo J, Jing Z . Hyperoside Protects Human Umbilical Vein Endothelial Cells Against Anticardiolipin Antibody-Induced Injury by Activating Autophagy. Front Pharmacol. 2020; 11:762. PMC: 7253676. DOI: 10.3389/fphar.2020.00762. View

2.
Reed G, Rossi J, Cannon C . Acute myocardial infarction. Lancet. 2016; 389(10065):197-210. DOI: 10.1016/S0140-6736(16)30677-8. View

3.
Bournele D, Beis D . Zebrafish models of cardiovascular disease. Heart Fail Rev. 2016; 21(6):803-813. DOI: 10.1007/s10741-016-9579-y. View

4.
Sattler S, Skibsbye L, Linz D, Lubberding A, Tfelt-Hansen J, Jespersen T . Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models. Front Cardiovasc Med. 2019; 6:158. PMC: 6848060. DOI: 10.3389/fcvm.2019.00158. View

5.
Ji D, Zhang L, Li C, Ye J, Zhu H . Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia. Vascul Pharmacol. 2008; 50(3-4):137-45. DOI: 10.1016/j.vph.2008.11.009. View